Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» CRISPR Therapeutics adds $38M to series B pot, but lags behind Parker
CRISPR Therapeutics adds $38M to series B pot, but lags behind Parker
CRISPR Therapeutics adds $38M to series B pot, but lags behind Parker
Submitted by
admin
on June 24, 2016 - 9:32am
Source:
Fierce Biotech
News Tags:
CRISPR Therapeutics
Series B
Sean Parker
CRISPR
Headline:
CRISPR Therapeutics adds $38M to series B pot, but lags behind Parker
Do Not Allow Advertisers to Use My Personal information
